Symposium Presentation 28.2
Next-Generation Fragile X PCR: Breaking Barriers to Enable Comprehensive FMR1 Molecular Analyses From Patient-Friendly Specimens

Friday, October 24, 2014 8:30 AM
Gary J. Latham, PhD, Vice President, Research and Technology Development, Asuragen Inc., Austin, TX
See more of: Fragile X-Associated Disorders: Illuminating the Spectrum of Disease Through Molecular, Clinical, and Therapeutic Advances
See more of: Symposium
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.